181 related articles for article (PubMed ID: 23668885)
21. Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma.
Ishikawa M; Miyahara R; Sonobe M; Horiuchi M; Mennju T; Nakayama E; Kobayashi M; Kikuchi R; Kitamura J; Imamura N; Huang CL; Date H
Lung Cancer; 2012 Jun; 76(3):431-8. PubMed ID: 22236865
[TBL] [Abstract][Full Text] [Related]
22. Eph signaling is regulated by miRNA-210: Implications for corneal epithelial repair.
Kaplan N; Liu M; Wang J; Yang W; Fiolek E; Peng H; Lavker RM
FASEB J; 2022 Jan; 36(1):e22076. PubMed ID: 34856019
[TBL] [Abstract][Full Text] [Related]
23. EphA2 stimulates VCAM-1 expression through calcium-dependent NFAT1 activity.
Funk SD; Finney AC; Yurdagul A; Pattillo CB; Orr AW
Cell Signal; 2018 Sep; 49():30-38. PubMed ID: 29793020
[TBL] [Abstract][Full Text] [Related]
24. Human dendritic cells express neuronal Eph receptor tyrosine kinases: role of EphA2 in regulating adhesion to fibronectin.
de Saint-Vis B; Bouchet C; Gautier G; Valladeau J; Caux C; Garrone P
Blood; 2003 Dec; 102(13):4431-40. PubMed ID: 12907451
[TBL] [Abstract][Full Text] [Related]
25. Targeted delivery of let-7a microRNA encapsulated ephrin-A1 conjugated liposomal nanoparticles inhibit tumor growth in lung cancer.
Lee HY; Mohammed KA; Kaye F; Sharma P; Moudgil BM; Clapp WL; Nasreen N
Int J Nanomedicine; 2013; 8():4481-94. PubMed ID: 24293999
[TBL] [Abstract][Full Text] [Related]
26. Ephrin-As, Eph receptors and integrin α3 interact and colocalise at membrane protrusions of U251MG glioblastoma cells.
Makarov A; Ylivinkka I; Nyman TA; Hyytiäinen M; Keski-Oja J
Cell Biol Int; 2013 Oct; 37(10):1080-8. PubMed ID: 23686814
[TBL] [Abstract][Full Text] [Related]
27. Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors.
Noberini R; Koolpe M; Peddibhotla S; Dahl R; Su Y; Cosford ND; Roth GP; Pasquale EB
J Biol Chem; 2008 Oct; 283(43):29461-72. PubMed ID: 18728010
[TBL] [Abstract][Full Text] [Related]
28. Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression.
Brantley-Sieders DM; Fang WB; Hicks DJ; Zhuang G; Shyr Y; Chen J
FASEB J; 2005 Nov; 19(13):1884-6. PubMed ID: 16166198
[TBL] [Abstract][Full Text] [Related]
29. Ligation of EphA2 by Ephrin A1-Fc inhibits pancreatic adenocarcinoma cellular invasiveness.
Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE
Biochem Biophys Res Commun; 2004 Aug; 320(4):1096-102. PubMed ID: 15249202
[TBL] [Abstract][Full Text] [Related]
30. Truncated EphA2 likely potentiates cell adhesion via integrins as well as infiltration and/or lodgment of a monocyte/macrophage cell line in the red pulp and marginal zone of the mouse spleen, where ephrin-A1 is prominently expressed in the vasculature.
Konda N; Saeki N; Nishino S; Ogawa K
Histochem Cell Biol; 2017 Mar; 147(3):317-339. PubMed ID: 27665280
[TBL] [Abstract][Full Text] [Related]
31. Drug-resistant cancer cell-derived exosomal EphA2 promotes breast cancer metastasis via the EphA2-Ephrin A1 reverse signaling.
Gao Z; Han X; Zhu Y; Zhang H; Tian R; Wang Z; Cui Y; Wang Z; Niu R; Zhang F
Cell Death Dis; 2021 Apr; 12(5):414. PubMed ID: 33879771
[TBL] [Abstract][Full Text] [Related]
32. Roles of EphA1/A2 and ephrin-A1 in cancer.
Ieguchi K; Maru Y
Cancer Sci; 2019 Mar; 110(3):841-848. PubMed ID: 30657619
[TBL] [Abstract][Full Text] [Related]
33. Targeting EphA2 in cancer.
Xiao T; Xiao Y; Wang W; Tang YY; Xiao Z; Su M
J Hematol Oncol; 2020 Aug; 13(1):114. PubMed ID: 32811512
[TBL] [Abstract][Full Text] [Related]
34. Attenuation of eph receptor kinase activation in cancer cells by coexpressed ephrin ligands.
Falivelli G; Lisabeth EM; Rubio de la Torre E; Perez-Tenorio G; Tosato G; Salvucci O; Pasquale EB
PLoS One; 2013; 8(11):e81445. PubMed ID: 24348920
[TBL] [Abstract][Full Text] [Related]
35. EphA2 receptor activation with ephrin-A1 ligand restores cetuximab efficacy in NRAS-mutant colorectal cancer cells.
Cuyàs E; Queralt B; Martin-Castillo B; Bosch-Barrera J; Menendez JA
Oncol Rep; 2017 Jul; 38(1):263-270. PubMed ID: 28560458
[TBL] [Abstract][Full Text] [Related]
36. Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival.
Herath NI; Spanevello MD; Sabesan S; Newton T; Cummings M; Duffy S; Lincoln D; Boyle G; Parsons PG; Boyd AW
BMC Cancer; 2006 Jun; 6():144. PubMed ID: 16737551
[TBL] [Abstract][Full Text] [Related]
37. A novel pH-dependent membrane peptide that binds to EphA2 and inhibits cell migration.
Alves DS; Westerfield JM; Shi X; Nguyen VP; Stefanski KM; Booth KR; Kim S; Morrell-Falvey J; Wang BC; Abel SM; Smith AW; Barrera FN
Elife; 2018 Sep; 7():. PubMed ID: 30222105
[TBL] [Abstract][Full Text] [Related]
38. Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice.
Brantley-Sieders DM; Fang WB; Hwang Y; Hicks D; Chen J
Cancer Res; 2006 Nov; 66(21):10315-24. PubMed ID: 17079451
[TBL] [Abstract][Full Text] [Related]
39. EphA receptors and ephrin-A ligands are upregulated by monocytic differentiation/maturation and promote cell adhesion and protrusion formation in HL60 monocytes.
Mukai M; Suruga N; Saeki N; Ogawa K
BMC Cell Biol; 2017 Aug; 18(1):28. PubMed ID: 28851287
[TBL] [Abstract][Full Text] [Related]
40. A conditional feedback loop regulates Ras activity through EphA2.
Macrae M; Neve RM; Rodriguez-Viciana P; Haqq C; Yeh J; Chen C; Gray JW; McCormick F
Cancer Cell; 2005 Aug; 8(2):111-8. PubMed ID: 16098464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
